{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:57:07Z","timestamp":1791262627535,"version":"4.1.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transactions of the Royal Society of Tropical Medicine and Hygiene"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.trstmh.2008.09.005","type":"journal-article","created":{"date-parts":[[2008,10,28]],"date-time":"2008-10-28T12:30:52Z","timestamp":1225197052000},"page":"280-290","source":"Crossref","is-referenced-by-count":67,"title":["Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine M\u00e9decins Sans Fronti\u00e8res programmes"],"prefix":"10.1093","volume":"103","author":[{"given":"Manica","family":"Balasegaram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Chappuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Priotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Eve","family":"Raguenaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Checchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1016\/j.trstmh.2008.09.005_bib1","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1371\/journal.pmed.0050055","article-title":"Eliminating human African trypanosomiasis: where do we stand and what comes next?","volume":"5","author":"Simarro","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.trstmh.2008.09.005_bib2","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.pt.2003.09.002","article-title":"Chemotherapy of human African trypanosomiasis: current and future prospects","volume":"19","author":"Fairlamb","year":"2003","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.trstmh.2008.09.005_bib3","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1046\/j.1365-3156.2001.00710.x","article-title":"Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis","volume":"6","author":"Blum","year":"2001","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.trstmh.2008.09.005_bib4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0035-9203(99)90151-7","article-title":"Risk factors for treatment failure after melarsoprol for Trypanosoma brucei gambiense trypanosomiasis in Uganda","volume":"93","author":"Legros","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.trstmh.2008.09.005_bib5","first-page":"171","article-title":"Therapeutic failure of melarsoprol among patients treated for late stage T.b. gambiense human African trypanosomiasis in Uganda [in French]","volume":"92","author":"Legros","year":"1999","journal-title":"Bull Soc Pathol Exot"},{"key":"10.1016\/j.trstmh.2008.09.005_bib6","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1046\/j.1365-3156.2001.00775.x","article-title":"The phenomenon of treatment failures in human African trypanosomiasis","volume":"6","author":"Brun","year":"2001","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.trstmh.2008.09.005_bib7","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1046\/j.1365-3156.2001.00724.x","article-title":"The situation of sleeping sickness in Angola: a calamity","volume":"6","author":"Stanghellini","year":"2001","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.trstmh.2008.09.005_bib8","series-title":"Mission report: information gathering and pre-implementation for HATSENTINEL network in Angola and Congo DRC","author":"Moore","year":"2002"},{"key":"10.1016\/j.trstmh.2008.09.005_bib9","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3201\/eid1106.050036","article-title":"Trypanosomiasis relapse after melarsoprol therapy, Democratic Republic of Congo, 1982\u20132001","volume":"11","author":"Pepin","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.trstmh.2008.09.005_bib10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1258\/004947506776593350","article-title":"The risk factors for relapse among patients with African trypanosomiasis in Daloa, Cote d\u2019Ivoire","volume":"36","author":"Cross","year":"2006","journal-title":"Trop Doct"},{"key":"10.1016\/j.trstmh.2008.09.005_bib11","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0140-6736(04)16940-7","article-title":"Efficacy of 10-day melarsoprol schedule 2 years after treatment for late-stage gambiense sleeping sickness","volume":"364","author":"Schmid","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.trstmh.2008.09.005_bib12","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1086\/432576","article-title":"Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis","volume":"41","author":"Chappuis","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.trstmh.2008.09.005_bib13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/bmj.39485.592674.BE","article-title":"Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study","volume":"336","author":"Priotto","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.trstmh.2008.09.005_bib14","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2471\/BLT.06.031955","article-title":"Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of the Congo","volume":"84","author":"Balasegaram","year":"2006","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.trstmh.2008.09.005_bib15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0035-9203(94)90430-8","article-title":"Gambiense trypanosomiasis: frequency of, and risk factors for, failure of melarsoprol therapy","volume":"88","author":"Pepin","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.trstmh.2008.09.005_bib16","first-page":"1284","article-title":"Short-course eflornithine in Gambian trypanosomiasis: a multicentre randomized controlled trial","volume":"78","author":"Pepin","year":"2000","journal-title":"Bull World Health Organ"},{"issue":"Supp 1","key":"10.1016\/j.trstmh.2008.09.005_bib17","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1007\/s00436-002-0766-5","article-title":"Eflornithine for the treatment of human African trypanosomiasis","volume":"90","author":"Burri","year":"2003","journal-title":"Parasitol Res"},{"key":"10.1016\/j.trstmh.2008.09.005_bib18","first-page":"559","article-title":"Eflornithine in the treatment of African trypanosomiasis","volume":"63","author":"Louis","year":"2003","journal-title":"Med Trop (Mars)"},{"key":"10.1016\/j.trstmh.2008.09.005_bib19","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.bjp.0707354","article-title":"Human African trypanosomiasis: pharmacological re-engagement with a neglected disease","volume":"152","author":"Barrett","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.trstmh.2008.09.005_bib20","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1086\/510534","article-title":"Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness","volume":"195","author":"Bisser","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.trstmh.2008.09.005_bib21","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/0140-6736(92)92180-N","article-title":"Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sickness","volume":"340","author":"Milord","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.trstmh.2008.09.005_bib22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4269\/ajtmh.1992.47.133","article-title":"The impact of human immunodeficiency virus infection on the epidemiology and treatment of Trypanosoma brucei gambiense sleeping sickness in Nioki, Zaire","volume":"47","author":"Pepin","year":"1992","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.trstmh.2008.09.005_bib23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0035-9203(93)90044-Q","article-title":"Eflornithine concentrations in serum and cerebrospinal fluid of 63 patients treated for Trypanosoma brucei gambiense sleeping sickness","volume":"87","author":"Milord","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.trstmh.2008.09.005_bib24","first-page":"119","article-title":"Macrophages as mediators of immunosuppression in murine African trypanosomiasis","volume":"117","author":"Askonas","year":"1985","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.trstmh.2008.09.005_bib25","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1086\/522982","article-title":"Nifurtimox\u2013eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo","volume":"45","author":"Priotto","year":"2007","journal-title":"Clin Infect Dis"}],"container-title":["Transactions of the Royal Society of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/trstmh\/article-pdf\/103\/3\/280\/5447009\/103-3-280.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T16:06:33Z","timestamp":1589040393000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/trstmh\/article-lookup\/doi\/10.1016\/j.trstmh.2008.09.005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0035920308003854"],"URL":"https:\/\/doi.org\/10.1016\/j.trstmh.2008.09.005","relation":{},"ISSN":["0035-9203"],"issn-type":[{"value":"0035-9203","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}